Cloudbreak Pharma

Cloudbreak Pharma, the Chinese branch of U.S.-based Cloudbreak Therapeutics LLC, is an ophthalmic drug discovery platform primarily focused on developing small-molecule multi-kinase inhibitor technology platforms and antibody-small molecule collaborative conjugation technology platforms, covering ocular surface, glaucoma, and fundus diseases.